Skip to content

Stepan SCL Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Huntsman logo
HuntsmanHUN
Dow logo
DowDOW
Innospec logo
InnospecIOSP
Ashland logo
AshlandASH
Avient logo
AvientAVNT
Chemours logo
ChemoursCC

Other financials

Income statement

See full
Revenue$604.5M+1.9%
Gross profit$64.9M-14.1%
Operating income-$49.6M-275%
Net income-$41.4M-310%
EPS (diluted)-$1.81-310%

Balance sheet

See full
Cash & equivalents$140.8M+31.0%
Total debt$713.1M-2.5%
Total equity$1.2B-0.6%
Total assets$2.3B-2.4%

Cash flow

See full
Operating cash flow$16.9M+144%
CapEx$30.9M-5.7%
Free cash flow-$14.0M+45.9%

Valuation

See full
Market cap$1.25B-8.6%
Enterprise value$1.82B-8.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin11.1%-1.4pp
Operating margin0%-3.5pp
Net margin-0.6%-3.1pp
FCF margin1.6%

Returns & leverage

See full
Return on equity-1.2%-5.8pp
Debt / equity0.6×0.0×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Stepan in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Stepan’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stepan's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stepan's accrued liabilities, current?
Stepan (SCL) reported accrued liabilities, current of $111.44M in Q1 2026.
How has Stepan's accrued liabilities, current changed year-over-year?
Stepan's accrued liabilities, current decreased by 1.3% year-over-year, from $112.87M to $111.44M.
What is the long-term trend for Stepan's accrued liabilities, current?
Over 5 years (2020 to 2025), Stepan's accrued liabilities, current has grown at a -3.5% compound annual growth rate (CAGR), from $141.95M to $119.04M.